- AI devices for Alzheimer's report poor demographic transparency.
- 24 devices were evaluated from FDA authorization.
- Only 41.7% disclosed any training data.
- None reported race or ethnicity.
- Most devices targeted volumetric brain structure quantification using MRI.
Source: JAMA
